Back

Cardiac amyloidosis awareness among physicians around the world: insights from an international survey

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms 3 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor David Niederseer

Hochgebirgsklinik Davos, Davos Wolfgang (Switzerland)

6 More presentations in this session

Presentation thumbnail
Iron deficiency as a predictor of the development of heart failure with preserved ejection fraction in women with type 2 diabetes mellitus
Doctor L. Petrovska (Ivano-Frankivsk, UA)
Abstract Slides Video
Presentation thumbnail
Obesity and diastolic dysfunction: unravelling the connection through exercise-stress-echocardiography cardiopulmonary test (CPET-ESE)
Doctor G. Spangaro (Milano, IT)
Abstract Slides Video
Presentation thumbnail
Characterization of patients with cardiac amyloidosis diagnosed at the time of idiopathic carpal tunnel surgery
Mr L. Santos (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Effect of the beta-2-selective agonist Salbutamol and the beta-1- selective antagonist Bisoprolol in a murine model of HFpEF
Miss R. Roshanbin (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The association between serum albumin levels and mortality in patients with heart failure with preserved ejection fraction
Associate Professor S. Murat (Eskisehir, TR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey
thumbnail
Congress Presentation
Accesses to anti-amyloid disease-modifying therapy impact awareness about cardiac amyloidosis and clinical practice: insights from an international survey
thumbnail
Congress Presentation
Traditional heart failure drug use in cardiac amyloid patients: insights from an international survey

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources